JEFFREY M JONAS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JEFFREY M JONAS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JEFFREY M JONAS. JEFFREY M JONAS is an Executive Vice President in IONIS PHARMACEUTICALS INC ($ISIS) and a Chief Innovation Officer in Sage Therapeutics, Inc. ($SAGE) and a President & CEO in Sage Therapeutics, Inc. ($SAGE) and a See Remarks in Sage Therapeutics, Inc. ($SAGE) and a Director in Generation Bio Co. ($GBIO) and a in Karuna Therapeutics, Inc. ($KRTX) and a Director in Karuna Therapeutics, Inc. ($KRTX).
Address: C/O ISIS PHARMACEUTICALS, INC. 1896 RUTHERFORD ROAD CARLSBAD 92008 CA
Companies in which JEFFREY M JONAS is an Insider
Generation Bio Co.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JEFFREY M JONAS: Director
Holdings: 0 shares
Latest Transaction: Jun 15 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IONIS PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JEFFREY M JONAS: Executive Vice President
Holdings: 0 shares
Latest Transaction: Jan 04 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Karuna Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JEFFREY M JONAS:
Holdings: 0 shares
Latest Transaction: Jun 08 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sage Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JEFFREY M JONAS: Chief Innovation Officer, President & CEO, See Remarks
Holdings: 66,330 shares
Current Value: $3,163,941
Latest Transaction: Jun 17 2021
$SAGE Market Capitalization: $1.75B
$SAGE Previous Close: $47.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of JEFFREY M JONAS
Sentiment: All, GBIO, ISIS, KRTX, SAGE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2021 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | Chief Innovation Of ... | Option Exercise | M | 0.45 | 12,000 | 5,400 | 46,587 | |
| Jun 17 2021 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | Chief Innovation Of ... | Buy | M | 0.45 | 12,000 | 5,400 | 75,237 | 63.2 K to 75.2 K (+18.98 %) |
| Jun 17 2021 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | Chief Innovation Of ... | Payment of Exercise | F | 58.80 | 3,093 | 181,868 | 63,237 | 66.3 K to 63.2 K (-4.66 %) |
| Jun 17 2021 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | Chief Innovation Of ... | Grant | A | 0.00 | 10,000 | 0 | 66,330 | 56.3 K to 66.3 K (+17.75 %) |
| Feb 12 2021 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | Chief Innovation Of ... | Option Exercise | A | 82.27 | 34,000 | 2,797,180 | 34,000 | |
| Jan 28 2021 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | Chief Innovation Of ... | Option Exercise | M | 0.45 | 1,800 | 810 | 58,587 | |
| Jan 28 2021 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | Chief Innovation Of ... | Buy | M | 0.45 | 1,800 | 810 | 56,330 | 54.5 K to 56.3 K (+3.30 %) |